Evidence map›Paper›PMID 24760988›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2014

Acylcarnitines activate proinflammatory signaling pathways.

Jennifer M Rutkowsky, Trina A Knotts, Kikumi D Ono-Moore, Colin S McCoin, Shurong Huang, Dina Schneider, Shamsher Singh, Sean H Adams, Daniel H Hwang

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 214 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
214citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

214 citing papers in PubMed, 1 synthesis or guideline pooled it, 322 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

154 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jennifer M RutkowskyDepartment of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California, Davis, California;
Trina A KnottsObesity and Metabolism Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California; Department of Nutrition, University of California, Davis, California;
Kikumi D Ono-MooreDepartment of Nutrition, University of California, Davis, California; Graduate Group in Nutritional Biology, University of California, Davis, California;
Colin S McCoinGraduate Group in Molecular, Cellular and Integrative Physiology, University of California, Davis, California; and.
Shurong HuangImmunity and Disease Prevention Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California.
Dina SchneiderImmunity and Disease Prevention Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California.
Shamsher SinghImmunity and Disease Prevention Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California.
Sean H AdamsObesity and Metabolism Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California; Department of Nutrition, University of California, Davis, California; Graduate Group in Nutritional Biology, University of California, Davis, California; Graduate Group in Molecular, Cellular and Integrative Physiology, University of California, Davis, California; and sean.h.adams@ars.usda.gov.
Daniel H HwangDepartment of Nutrition, University of California, Davis, California; Graduate Group in Nutritional Biology, University of California, Davis, California; Immunity and Disease Prevention Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California.
University of California, Davis · USAgricultural Research Service · USWestern Human Nutrition Research Center · US

Funding

Identification of Muscle-Specific Biomarkers of Fatty Acid beta-OxidationR01DK078328 · NIDDK · U.S. AGRICULTURAL RESEARCH SERVICE · PI ADAMS, SEAN HARRISON · 2008 to 2012
$1.8M
NIDDK NIH HHS R01DK078328NIDDK NIH HHS R01DK078328-02S1
6 · The paper itself

Abstract

Incomplete β-oxidation of fatty acids in mitochondria is a feature of insulin resistance and type 2 diabetes mellitus (T2DM). Previous studies revealed that plasma concentrations of medium- and long-chain acylcarnitines (by-products of incomplete β-oxidation) are elevated in T2DM and insulin resistance. In a previous study, we reported that mixed D,L isomers of C12- or C14-carnitine induced an NF-κB-luciferase reporter gene in RAW 264.7 cells, suggesting potential activation of proinflammatory pathways. Here, we determined whether the physiologically relevant L-acylcarnitines activate classical proinflammatory signaling pathways and if these outcomes involve pattern recognition receptor (PRR)-associated pathways. Acylcarnitines induced the expression of cyclooxygenase-2 in a chain length-dependent manner in RAW 264.7 cells. L-C14 carnitine (5-25 μM), used as a representative acylcarnitine, stimulated the expression and secretion of proinflammatory cytokines in a dose-dependent manner. Furthermore, L-C14 carnitine induced phosphorylation of JNK and ERK, common downstream components of many proinflammatory signaling pathways including PRRs. Knockdown of MyD88, a key cofactor in PRR signaling and inflammation, blunted the proinflammatory effects of acylcarnitine. While these results point to potential involvement of PRRs, L-C14 carnitine promoted IL-8 secretion from human epithelial cells (HCT-116) lacking Toll-like receptors (TLR)2 and -4, and did not activate reporter constructs in TLR overexpression cell models. Thus, acylcarnitines have the potential to activate inflammation, but the specific molecular and tissue target(s) involved remain to be identified.

Indexed as

Macrophage ActivationMAP Kinase Signaling SystemAnimalsCarnitineCell Line, TransformedCell Line, TumorCyclooxygenase 2CytokinesDiabetes Mellitus, Type 2Docosahexaenoic AcidsEnzyme InductionGene SilencingHumansMacrophagesMiceMyeloid Differentiation Factor 88acylcarnitineCarnitineCyclooxygenase 2CytokinesDocosahexaenoic AcidsMyd88 protein, mouseMyeloid Differentiation Factor 88Myristic AcidsmyristoylcarnitinePtgs2 protein, mouseReceptors, Pattern RecognitionRecombinant ProteinsTlr2 protein, mouseToll-Like Receptor 2acylcarnitineinflammationpattern recognition receptorsTLRβ-oxidation

Identifiers

PMID24760988
PMCPMC4059985
OpenAlexW2028621708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.